You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
戴維醫療(300314.SZ):前三季度淨利預增160%—190%
格隆匯 09-30 20:06

格隆匯 9 月 30日丨戴維醫療(300314.SZ)公佈2020年前三季度業績預告,2020年1月1日—2020年9月30日公司實現歸屬於上市公司股東的淨利潤:1.05元—1.17億元,比上年同期增長:160%—190%。其中,2020年第三季度實現歸屬於上市公司股東的淨利潤:4919.91萬元—5534.90萬元,比上年同期增長:140%—170%。

報告期內,公司一方面繼續實施現有經營方針,穩固國內外市場,另一方面提升核心競爭力,開發新產品,開拓新市場,公司嬰兒保育設備業務繼續保持穩定增長,同時吻合器業務進一步取得較快增長。

報告期內,參股公司深圳市陽和生物醫藥產業投資有限公司(以下簡稱“陽和投資”)對外投資的南京偉思醫療科技股份有限公司因二級市場股票價格上漲,導致陽和投資賬面浮動盈利較大,進而影響本公司對其權益法核算的投資收益上漲較多,受該投資業務的影響,預計增加公司淨利潤約3500萬元。

報告期內,預計非經常性損益約為860萬元左右,去年同期為893萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account